• / Free eNewsletters & Magazine
  • / My Account
Home>NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis

NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis

3party Content

Mon, 22 Dec 2014

First-ever clearance of its kind in the US creates an important new option for patients and providers to perform home hemodialysis overnight while sleepingLAWRENCE, Mass., Dec. 22, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products,
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.